108. TNF receptor-associated periodic syndrome
4 clinical trials,   7 drugs   (DrugBank: 1 drug),   1 drug target gene,   42 drug target pathways

Searched query = "TNF receptor-associated periodic syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2010-020061-24-IT
(EUCTR)
20/09/201005/07/2010An open-label, multicenter, efficacy and safety study of 4-month canakinumab treatment with 6-month follow-up in patients with active recurrent or chronic TNF-receptor associated periodic syndrome (TRAPS) - NDAn open-label, multicenter, efficacy and safety study of 4-month canakinumab treatment with 6-month follow-up in patients with active recurrent or chronic TNF-receptor associated periodic syndrome (TRAPS) - ND Active recurrent or chronic TNF-receptor associated periodic syndrome (TRAPS)
MedDRA version: 12.1;Level: LLT;Classification code 10034533;Term: Periodic fever
Product Name: canakinumab
Product Code: ACZ885D
INN or Proposed INN: Canakinumab
NOVARTIS FARMANULLNot RecruitingFemale: yes
Male: yes
50Ireland;United Kingdom;Italy